Likewise, YKL-40 controls key pathways and processes within the tumour microenvironment, including inflammation, angiogenesis, cell proliferation, differentiation, and the remodelling of the extracellular matrix and thus promotes tumour progression [15]. This evidence concerns the gene CHI3L1 and neoplasm.